Clinical Trial Update: Duration of Dual Anti-Platelet Therapy (DUAL-ACS) [Phase 4]

View source ↗

Summary

This update reports results from a Phase 4 trial evaluating the optimal duration of dual antiplatelet therapy in patients with acute coronary syndrome and coron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: University of Edinburgh | Conditions: Acute Coronary Syndrome, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2026-01-28